Jordan E. Grushkin

Jordan Grushkin is an associate in the Corporate Practice Group in the firm’s Century City office and is a member of the firm’s healthcare practice team.

Areas of Practice

Jordan’s practice focuses on the transactional and regulatory aspects of healthcare law, and includes representation of a wide variety of healthcare entities, from providers such as hospitals and medical groups to payors and intermediary entities (e.g., independent practice associations (IPAs) and risk-bearing entities). On the corporate side, Jordan counsels clients on mergers and acquisitions and other strategic transactions in the healthcare space. His experience includes advising on corporate structuring, governance and operational matters, drafting transactional documents and managing due diligence investigations. From a healthcare regulatory perspective, Jordan has extensive experience navigating businesses through the regulatory approval processes and ensuring compliance on the federal, state and local level.

Articles

Healthcare Law Blog Posts

• "Texas v. California: SCOTUS Hears Oral Arguments About the Constitutionality of the ACA," November 17, 2020
• "ERISA: The Erosion of State Health Regulation Rights," November 24, 2020
• "The Death of RBG…and the ACA?," September 25, 2020

• "Getting Ahead of California’s Post-Pandemic M&A Surge: California Senate Bill 977 Seeks to Expand Attorney General Oversight of Healthcare Acquisitions and Affiliations involving Hospitals, Health Systems, Private Equity Groups, and Hedge Funds," May 28, 2020

• "Will COVID-19 Prompt “Holdout States” to Reconsider Medicaid Expansion?," May 26, 2020

• "Elective and Non-Essential Medical Procedures: States React to Federal Recommendations and the Opening Up America Again Guidelines," April 23, 2020

• "CMS Issues COVID-19 Prevention Guidance for PACE Organizations," April 6, 2020

• "JUST IN: Fifth Circuit Court of Appeals Reaches Decision on Latest Case Involving Constitutionality of ACA," December 18, 2019

• "Adventist – St. Joseph Merger: AG Concludes Merger is Not in the Public Interest," November 14, 2019

• "Update to Texas v. United States: DOJ Files a Brief in Support of Eliminating the ACA," May 6, 2019 
• "Update to Texas v. United States," April 4, 2019 
• "340B Drug Pricing Program Litigation Update: Court Rejects CMS Drug Pricing Cuts," January 14, 2019
• "Texas v. United States: Texas Federal Court 'Strikes Down' the ACA," December 19, 2018 
• "Reforming America’s Healthcare System Through Choice and Competition: The Trump Administration Recommends Healthcare De-Regulation," December 18, 2018 
• "Midterms Bring New Focus to Healthcare," November 12, 2018 
• "New California Law re HMO M&A," November 2, 2018 
• "More Than 700 CEOs of Hospitals and Health Systems Write to Congress to Stop Cuts to the 340B Drug Pricing Program," October 10, 2018 
• "Federal Antitrust Regulators Approve Cigna’s Proposed Acquisition of Express Scripts," September 20, 2018 
• "The Blame Game: Senators Clash with the Trump Administration," September 4, 2018 
• "CMS Continues to Push for Hospital Price Transparency in Final Rule," August 10, 2018 
• "The Trump Administration Allows for Longer 'Short-Term' Health Insurance Policies, but Coverage Stays the Same," August 3, 2018
• "Following Repeal of the Individual Mandate, Twenty States Challenge the Affordable Care Act," June 15, 2018 
• "CMS Pushes for Hospital Price Transparency in Proposed Rule," May 11, 2018
• "CMS Proposes “Wind Down” Plan for Federal Exchanges," April 12, 2018 
• "California Sues Sutter Health Alleging Anti-Competitive Practices," April 6, 2018 
• "New DOJ Guidance Policy Limits Use of Guidance Documents in Federal Civil Actions," February 20, 2018 
• "The Bipartisan Budget Act Boosts Medicare: Flexibility and Financing for Healthcare Plans and Providers," February 15, 2018 
• "340B Drug Pricing Program Litigation Update," January 4, 2018 
• "Have the Reports of the Affordable Care Act’s Death Been Greatly Exaggerated?" January 2, 2018
• "President Trump Signs Tax Reform Bill Into Law," December 22, 2017
• "The 340B Drug Pricing Program: New CMS Final Rule Draws a Motion for Preliminary Injunction from Hospital Groups," November 17, 2017 
• "Clean Up on Aisle 12! The Obamacare Pop-Up Store is Open but Stocks are Limited," November 3, 2017 
• "Trump Administration Pulls the Plug on CSR Payments," October 13, 2017 
• "Trump Administration Takes Aim at ACA With AHP Executive Order," October 13, 2017
• "Nine Days and Counting – The Fate of CHIP Remains Uncertain Amid Congressional Deadlock," October 9, 2017  
• "Disproportionate Share Hospitals Facing Steep Payment Cuts," September 28, 2017 
• "Effects of Insurance Marketplace Uncertainty," September 21, 2017
• "CMS Aims to Nix Obama-Era Payment Models,"  August 30, 2017
• "ACA Cost-Sharing Reductions– A Momentary Reprieve and Ongoing Doubts," August 25, 2017
• "Recent Department of Justice Crackdown on Fraud and Abuse," July 24, 2017
• "Part VIII: BCRA – What Is Dead May Never Die," July 18, 2017 
• "Part VII: The Senate’s Response to the American Health Care Act," June 29, 2017
• "ACA Cost-Sharing Reductions: An Uncertain Future," May 5, 2017
• "Part VI: An Update on the American Health Care Act," May 5, 2017 
• "Jury Returns Massive Verdict in Hospital Gown Fraud Lawsuit," April 13, 2017 
• "Health-Related Programs Face Deep Cuts In President Trump’s 'Budget Blueprint to Make America Great Again,'" March 30, 2017

• "Part V: A Brief Overview of the American Health Care Act," March 9, 2017

• "New OIG Exclusion Authority Rule Set To Go Into Effect on March 21, 2017," March 8, 2017

• "The 340B Program Omnibus Guidance: Not Ready for Prime Time," February 21, 2017

• "Part IV: The ACA, Post-Inauguration," February 7, 2017
• "Part III: Exploring 'Repeal and Replace,'" December 21, 2016

• "Part II: Implications of a Partial Obamacare Repeal," December 6, 2016

• "Part I: How We Got Here: President Obama to Obamacare to President-elect Trump," November 18, 2016

• "ACA and Drug Prices Drive U.S. Healthcare Spending Surge," December 21, 2015